Literature DB >> 16229490

Nucleotide binding to the multidrug resistance P-glycoprotein as studied by ESR spectroscopy.

Sabine Delannoy1, Ina L Urbatsch, Gregory Tombline, Alan E Senior, Pia D Vogel.   

Abstract

Electron spin resonance (ESR) spectroscopy using spin-labeled ATP was used to study nucleotide binding to and structural transitions within the multidrug resistance P-glycoprotein, P-gp. Spin-labeled ATP (SL-ATP) with the spin label attached to the ribose, was observed to be an excellent substrate analogue for P-gp. SL-ATP was hydrolyzed in a drug-stimulated fashion at about 14% of the rate for normal ATP and allowed reversible trapping of the enzyme in transition and ground states. Equilibrium binding of a total of two nucleotides per P-gp was observed with a binding affinity of 366 microM in the presence of Mg2+ but in the absence of transport substrates such as verapamil. Binding of SL-ATP to wild-type P-gp in the presence of verapamil resulted in reduction of the protein-bound spin-label moiety, most likely due to a conformational transition within P-gp that positioned cysteines in close proximity to the spin label to allow chemical reduction of the radical. We circumvented this problem by using a mutant of P-gp in which all naturally occurring cysteines were substituted for alanines. Equilibrium binding of SL-ATP to this mutant P-gp resulted in maximum binding of two nucleotides; the binding affinity was 223 microM in the absence and 180 microM in the presence of verapamil. The corresponding ESR spectra of wild-type and Cys-less P-gp in the presence of SL-ATP indicate that a cysteine side chain of P-gp is located close to the ribose of the bound nucleotide. Trapping SL-ATP as an AlF(x)-adduct resulted in ESR spectra that showed strong immobilization of the radical, supporting the formation of a closed conformation of P-gp in its transition state. This study is the first to employ ESR spectroscopy with the use of spin-labeled nucleotide analogues to study P-glycoprotein. The study shows that SL-ATP is an excellent substrate analogue that will allow further exploration of structure and dynamics within the nucleotide binding domains of this important enzyme.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16229490     DOI: 10.1021/bi0512445

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  21 in total

1.  P-glycoprotein retains drug-stimulated ATPase activity upon covalent linkage of the two nucleotide binding domains at their C-terminal ends.

Authors:  Brandy Verhalen; Stephan Wilkens
Journal:  J Biol Chem       Date:  2011-01-28       Impact factor: 5.157

2.  Using a cysteine-less mutant to provide insight into the structure and mechanism of CFTR.

Authors:  Tip W Loo; David M Clarke
Journal:  J Physiol       Date:  2006-02-23       Impact factor: 5.182

3.  Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket.

Authors:  Tip W Loo; M Claire Bartlett; David M Clarke
Journal:  Biochem J       Date:  2006-10-15       Impact factor: 3.857

4.  Structural basis of p38α regulation by hematopoietic tyrosine phosphatase.

Authors:  Dana M Francis; Bartosz Różycki; Dorothy Koveal; Gerhard Hummer; Rebecca Page; Wolfgang Peti
Journal:  Nat Chem Biol       Date:  2011-11-06       Impact factor: 15.040

5.  Optimizing Targeted Inhibitors of P-Glycoprotein Using Computational and Structure-Guided Approaches.

Authors:  John G Wise; Amila K Nanayakkara; Maha Aljowni; Gang Chen; Maisa C De Oliveira; Lauren Ammerman; Ketetha Olengue; Alexander R Lippert; Pia D Vogel
Journal:  J Med Chem       Date:  2019-11-26       Impact factor: 7.446

6.  The ATPase activity of the P-glycoprotein drug pump is highly activated when the N-terminal and central regions of the nucleotide-binding domains are linked closely together.

Authors:  Tip W Loo; M Claire Bartlett; Michael R Detty; David M Clarke
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

7.  In silico screening for inhibitors of p-glycoprotein that target the nucleotide binding domains.

Authors:  Frances K Brewer; Courtney A Follit; Pia D Vogel; John G Wise
Journal:  Mol Pharmacol       Date:  2014-09-30       Impact factor: 4.436

8.  Identification of the distance between the homologous halves of P-glycoprotein that triggers the high/low ATPase activity switch.

Authors:  Tip W Loo; David M Clarke
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

9.  Cysteines introduced into extracellular loops 1 and 4 of human P-glycoprotein that are close only in the open conformation spontaneously form a disulfide bond that inhibits drug efflux and ATPase activity.

Authors:  Tip W Loo; David M Clarke
Journal:  J Biol Chem       Date:  2014-07-22       Impact factor: 5.157

10.  Effects of small molecule modulators on ATP binding to skeletal ryanodine receptor.

Authors:  José M Dias; Pia D Vogel
Journal:  Protein J       Date:  2009-06       Impact factor: 2.371

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.